Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort
Open Access
- 17 February 1999
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 281 (7) , 650-655
- https://doi.org/10.1001/jama.281.7.650
Abstract
Hypertrophic cardiomyopathy (HCM) is a complex familial cardiac disease with heterogeneous clinical, morphologic, and genetic expression.1-4 Since its initial description 40 years ago, HCM has been largely regarded to be associated with substantial disability and premature death, and annual mortality rates as high as 3% to 6% have been reported.1,3,5-14Keywords
This publication has 15 references indexed in Scilit:
- Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan SyndromeCirculation, 1998
- The Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 1997
- Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional populationJournal of the American College of Cardiology, 1995
- Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathyHeart, 1994
- Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient PopulationNew England Journal of Medicine, 1989
- Hypertrophic cardiomyopathy: an important cause of sudden death.Archives of Disease in Childhood, 1984
- Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic featuresThe American Journal of Cardiology, 1981
- Idiopathic hypertrophic subaortic stenosis in the youngThe American Journal of Cardiology, 1978
- Asymmetric septal hypertrophy in childhoodHuman Pathology, 1977
- Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy.Heart, 1971